In the first few days of life, it is normal for all newborns to have a mild rise in bilirubin levels because their liver is still learning to process this waste product. However, when the yellow hue becomes noticeable, especially if it spreads beyond the eyes to the face, torso, or limbs, it may indicate a level of bilirubin that requires medical attention.

Common Causes

Most cases of newborn jaundice are benign and resolve with simple measures, but several conditions can increase bilirubin production or impair its removal. The following are the most frequent causes of yellow eyes in newborns:

• Physiologic (normal) newborn jaundice – occurs in 60‑80 % of term infants within the first 2–3 days of life.
• Breast‑feeding jaundice – inadequate milk intake leads to dehydration and slower bilirubin clearance.
• Breast‑milk jaundice – substances in breast‑milk interfere with bilirubin metabolism, often peaking at 2‑3 weeks.
• Hemolytic disease of the newborn (HDN) – caused by blood‑type incompatibility (e.g., Rh or ABO), leading to rapid red‑cell breakdown.
• Neonatal hemolysis from genetic conditions – such as G6PD deficiency or hereditary spherocytosis.
• Infection – sepsis, urinary tract infection, or viral hepatitis can impair liver function.
• Prematurity – immature liver enzymes handle bilirubin less efficiently.
• Congenital liver disorders – biliary atresia, neonatal hepatitis, or metabolic diseases (e.g., Crigler‑Najjar syndrome).
• Blood loss or bruising during delivery – increases red‑cell breakdown.
• Medications or maternal drugs – certain antibiotics or maternal medications can affect bilirubin metabolism.

Associated Symptoms

Yellow eyes rarely appear in isolation. Look for these accompanying signs, which can help narrow the cause and indicate severity:

• General yellowing of the skin, first on the face, then spreading downwards.
• Lethargy or unusual sleepiness.
• Poor feeding or difficulty latching.
• High‑pitched crying or irritability.
• Dark urine and pale (chalky) stools.
• Rapid heart rate or breathing difficulties.
• Enlarged liver or spleen (detectable on physical exam).
• Bruising, petechiae, or a rash (possible sign of hemolysis or infection).

When to See a Doctor

Because newborns cannot verbalize how they feel, parents must be vigilant. Contact a pediatrician or seek urgent care if you notice any of the following:

• Yellow color that spreads beyond the eyes to the chest, abdomen, or limbs.
• The baby is difficult to awaken, unusually sleepy, or not feeding well.
• Vomiting, especially if it contains bile.
• Fever ≥ 38 °C (100.4 °F) or a low body temperature.
• Rapid breathing, grunting, or a bluish tint around the mouth.
• Any signs of dehydration – dry mouth, no wet diapers for >6 hours.
• Known risk factors (prematurity, blood‑type incompatibility, G6PD deficiency) and bilirubin is rising quickly.

When in doubt, call your pediatrician. Early evaluation reduces the risk of bilirubin‑induced brain injury (kernicterus).

Diagnosis

Doctors use a combination of visual assessment, laboratory testing, and sometimes imaging to determine the cause and severity of jaundice.

1. Visual assessment & timing

• Examination of the extent of yellowing (eyes only, face, trunk, limbs).
• Recording the infant’s age in hours – bilirubin peaks differ by gestational age.

2. Serum bilirubin measurement

• Total serum bilirubin (TSB) – drawn from a heel‑stick or venous sample.
• Results are plotted on a transcutaneous bilirubin nomogram (or “bilirubin chart”) that accounts for age in hours and risk factors.

3. Blood tests to identify underlying causes

• Complete blood count (CBC) and reticulocyte count – look for hemolysis.
• Blood type and Coombs test – assess for ABO or Rh incompatibility.
• G6PD screening (especially in high‑risk ethnic groups).
• Liver function panel (ALT, AST, GGT) if a hepatic problem is suspected.
• Blood cultures if infection is a concern.

4. Imaging (when indicated)

• Abdominal ultrasound – evaluates for biliary atresia or structural liver disease.
• Hepatobiliary iminodiacetic acid (HIDA) scan – assesses bile flow if biliary atresia is suspected.

Treatment Options

The goal is to lower bilirubin to safe levels while treating any underlying condition. Treatment varies by severity and cause.

1. Phototherapy (light therapy)

• Standard of care for most newborns with TSB > 12‑15 mg/dL (depending on age and risk).
• Blue‑green light (≈460 nm) transforms bilirubin into water‑soluble isomers that can be eliminated via urine and stool.
• Types:
  • Conventional overhead lights.
  • LED or fiber‑optic blankets – more efficient and quieter.
• Typical duration: 12‑48 hours, reassessed with repeat bilirubin levels.

2. Exchange transfusion

• Reserved for severe hyperbilirubinemia (usually TSB > 20‑25 mg/dL) or rapid rise despite phototherapy.
• Gradually replaces the infant’s blood with donor blood, rapidly lowering bilirubin and removing antibodies.

3. Enhancing breastfeeding

• Frequent, effective feeding (8‑12 times/24 h) promotes stool output and bilirubin excretion.
• Lactation consultant support to improve latch and milk supply.

4. Intravenous immunoglobulin (IVIG)

• Used when hemolytic disease is due to maternal antibodies (e.g., Rh incompatibility).
• Reduces antibody‑mediated red‑cell destruction, decreasing bilirubin production.

5. Addressing underlying causes

• Antibiotics for confirmed infection.
• Surgical correction (e.g., Kasai porto‑enterostomy) for biliary atresia, ideally before 8 weeks of age.
• Discontinuation of offending drugs if medication‑related.

6. Home care after discharge

• Continue regular feeding.
• Track urine/stool output (≥6 wet diapers/day, soft yellow stools).
• Follow‑up bilirubin checks as directed (often 24‑48 h after discharge).

Prevention Tips

While some causes are unavoidable (e.g., physiologic jaundice), many steps can reduce the risk or severity of yellow eyes in newborns:

• Early and frequent feeding – aim for at least 8–12 breast‑milk or formula feeds per day during the first week.
• Monitor weight gain – newborns should regain birth weight by day 10–14; insufficient gain signals inadequate intake.
• Educate about normal jaundice – parents should know that mild yellowing of the face in the first 24‑48 h is common, but spreading jaundice warrants a call.
• Check blood type & Rh status – prenatal screening allows early planning for at‑risk infants.
• Vitamin D supplementation – recommended for breastfed infants, may aid overall health and feeding success.
• Avoid over‑use of sunlamps – natural sunlight can help mild jaundice but never replace medical phototherapy.
• Prompt treatment of maternal conditions – manage maternal diabetes, infections, or medication use that could affect bilirubin metabolism.
• Vaccinate caregivers – reduces infant exposure to infections that could trigger liver dysfunction.

Emergency Warning Signs

If any of the following appear, seek emergency medical care (ER or call 911) immediately:

• Yellowing that spreads rapidly to the abdomen, thighs, or whole body.
• Extreme lethargy – the baby cannot be roused for feeding.
• High‑pitched, incessant crying or inconsolable fussiness.
• Seizures or abnormal movements.
• Breathing difficulty, grunting, or bluish lips.
• Temperature ≥ 38 °C (100.4 °F) or < 35 °C (95 °F).
• Vomiting repeatedly or inability to keep any feed down.
• Few or no wet diapers (≤ 2 in 24 h).

References:

• Mayo Clinic. “Newborn jaundice.” https://www.mayoclinic.org
• American Academy of Pediatrics. “Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.” Pediatrics, 2022.
• Centers for Disease Control and Prevention. “Neonatal Jaundice.” https://www.cdc.gov
• National Institute of Child Health & Human Development. “Biliary Atresia.”
• Cleveland Clinic. “Jaundice in Newborns – Causes & Treatment.”